Granules India Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 12,34,957 shares,. Its Average Traded Price (ATP) is ₹820.12, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹813.20.
Granules India has an upper circuit limit of ₹975.80 and a lower circuit limit of ₹650.60. The total value traded stands at ₹101.28 CR, and the delivery percentage for the day is 33.29%.
The stock is currently traded with a market lot size of 1. Granules India also offers a dividend yield of 0.21%.
Granules India Share Price Chart
Granules India Share Key Metrics
Volume
12.35 L
Market Cap
20150.85 CR
LTQ@LTP
2@813.20
ATP
820.12
Var Margin
16.19 %
Circuit Range
650.6-975.8
Delivery %
33.29 %
Value
101.28 CR
ASM/GSM
No
Market Lot
1
Granules India Resistance and Support
Pivot 828.17
Resistance
First Resistance
859.34
Second Resistance
878.17
Third Resistance
909.34
Support
First Support
809.34
Second Support
778.17
Third Support
759.34
Granules India Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Granules India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-07-21 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-06 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-30 | 2026-07-30 | View More |
Granules India News
Granules India Ltd-$ - 532482 - Board Meeting Outcome for Outcome Of The Board Meeting Dated November 02, 2026.
Granules reported Q2 FY27 cons. revenue of ₹1,560 crores (up 20% YoY) and net profit of ₹182 crores (up 39% YoY). The company allotted 24.98 million equity shares upon conversion of warrants and received ₹1,096 crores in balance subscription. Furthermore, the USFDA issued a Form 483 for its Gagillapur facility with observations unrelated to data integrity or cross-contamination.
Nov 02 2026 16:50:16
Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India announced that the USFDA issued 11 observations for its Gagillapur facility following an inspection from October 19 to 30, 2026. The company stated that none of the observations pertain to data integrity or cross-contamination, and manufacturing remains unaffected.
Oct 30 2026 22:47:44
Granules India Ltd-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Granules India promoter group acquired 2.49 crore warrants convertible into equity shares on a preferential basis. The warrants were allotted at Rs.585 each, increasing the promoter group's total diluted shareholding to 43.69%.
Oct 24 2026 11:43:37
Granules India Ltd-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Granules India's promoter group acquired 2,49,82,906 equity shares, representing a 9.16% stake, through the conversion of preferential warrants. This increases the total promoter holding to 37.39%.
Oct 24 2026 11:42:07
Granules India Ltd-$ - 532482 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Dr Krishna Prasad Chigurupati sold 1,72,00,000 equity shares of Granules India, accounting for a 6.94% stake. Post this transaction, his holding in the company stands reduced from 31.00% to 24.06%.
Oct 24 2026 11:39:23
Granules India Ltd-$ - 532482 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Second Quarter And Half-Year Ended On September 30, 2026
Granules board to meet on 02 November 2026 for financial results. The meeting will cover the quarter and half-year ended September 2026.
Oct 23 2026 15:25:21
Granules India Management
| Name | Position |
|---|---|
| Krishna Prasad Chigurupati | Chairman & Managing Director |
| Uma Devi Chigurupati | Whole Time Director |
Granules India Similar Stocks
Piramal Pharma Ltd.
244.54
-0.53 (0.22%)
Acutaas Chemicals Ltd.
4039.10
43.00 (1.08%)
Krishna Institute of Medical Sciences Ltd
729.65
2.35 (0.32%)
Rubicon Research Ltd.
1677.20
-40.10 (2.34%)
Neuland Laboratories Ltd.
21078.00
155.00 (0.74%)
Alembic Pharmaceuticals Ltd.
1030.15
-17.10 (1.63%)
Caplin Point Laboratories Ltd.
2388.70
2.40 (0.10%)
Astrazeneca Pharma India Ltd.
6031.50
-407.00 (6.32%)
Shilpa Medicare Ltd.
991.50
1.85 (0.19%)
Onesource Specialty Pharma Ltd.
1610.10
-9.90 (0.61%)
Granules India FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GRANULES
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC